RESULTS ROUND-UP: Hologic on the up, Wright suffers from softness; Thoratec, Insulet
This article was originally published in Clinica
Women’s health specialist Hologic said it has turned the corner, posting growth in all its key businesses in the fourth fiscal quarter ending 27 September. The firm’s Q4 revenue of $660.6m, up 6% from the same period last year, was helped by a 2% increase in Diagnostics revenue (at $297.1m), a 3% increase in Breast Health ($241.5m), a 2% increase in GYN Surgical ($78.5m) and a 10% increase Skeletal Health ($23.4m). Hologic’s largest franchise, Diagnostics, benefited from growth in its molecular diagnostics and blood screening lines, but this was partially offset by acontinuing decrease in US sales of its ThinPrep pap tests, which the company blamed on “interval expansion”.